Criteria for considering studies for this review
There were no restrictions on the article’s publication date. We
evaluated all case reports, case series and observational studies that
were about the prevalence of PCP in patients with AML. Studies with
relevant information were included in the final analysis. Titles,
abstracts, and full texts of the recorded studies were evaluated based
on the inclusion and exclusion criteria. The inclusion criteria were as
follows: 1) studies including clinical trials, observational studies,
case reports, case series and case letters on PCP and AML. We select
papers with no date restriction which evaluated incidence of PCP in AML
patients, clinical manifestations, chemotherapy regimen, phase of
treatment and also outcome; 2) availability to the full-text articles;
3) only English language articles. Studies with at least one of the
following aspects were excluded: 1) studies with non-relevant
information, 2) studies with language other than English, 3) review
articles and letters, 4) duplicate studies and 5) articles available
only in abstract form. Appropriate papers were selected after evaluating
all studies based on the inclusion and exclusion criteria.